Dosage forms

IHS Announces CE Mark Certification for Proprietary Syringe Infusion System

Retrieved on: 
Thursday, July 22, 2021
Hospitals, Health, Surgery, Medical devices, Health sciences, Medicine, Dosage forms, Pharmacology, Routes of administration, Injection, Medical equipment, Infusion pump, Infusion therapy, Intravenous therapy, ISO 13485, Subcutaneous injection

Innovative Health Sciences, LLC (IHS or the Company) announced today that they have received ISO 13485 quality management system and CE mark certification for the Insignis Syringe Infusion System.

Key Points: 
  • Innovative Health Sciences, LLC (IHS or the Company) announced today that they have received ISO 13485 quality management system and CE mark certification for the Insignis Syringe Infusion System.
  • The CE mark, abbreviated for European Conformity ("Conformit Europene"), enables IHS to sell the system throughout the European Union.
  • The Insignis Syringe Infusion System is the first combination of intravenous and subcutaneous non-electric infusion pump created for use with a selectable rate flow controller, the IV Controller and the OneSett.
  • The IHS infusion system addresses nearly every infusion therapy need and can support intermittent, pause dosing, ideal for lengthy low-volume hospital infusions.

CCELL® Announces the Launch of Listo Disposable Vaporizer

Retrieved on: 
Wednesday, July 21, 2021
Dosage forms, Cannabis smoking, Health sciences, Pharmacology, Vaporizer, NJOY, Articles, Rechargeable battery, Disposable product

The Listo Vaporizer is designed with a 350mAh built-in battery and a rechargeable USB port to ensure enjoyment until the last drop.

Key Points: 
  • The Listo Vaporizer is designed with a 350mAh built-in battery and a rechargeable USB port to ensure enjoyment until the last drop.
  • We are incredibly proud of the design of our new Listo Vaporizer, especially from a safety perspective and design perspective, said Joe S., VP of CCELL.
  • Compared to other disposable vaporizers, Listo is superior because of its patented CCELL vaporizing technology, compact design, safety features, and ergonomic grip, which makes it comfortable to hold.
  • With Listo, CCELL offers consumers everything needed in a disposable vaporizer.

CCELL® Announces the Launch of Listo Disposable Vaporizer

Retrieved on: 
Wednesday, July 21, 2021
Dosage forms, Cannabis smoking, Health sciences, Pharmacology, Vaporizer, NJOY, Articles, Rechargeable battery, Disposable product

The Listo Vaporizer is designed with a 350mAh built-in battery and a rechargeable USB port to ensure enjoyment until the last drop.

Key Points: 
  • The Listo Vaporizer is designed with a 350mAh built-in battery and a rechargeable USB port to ensure enjoyment until the last drop.
  • We are incredibly proud of the design of our new Listo Vaporizer, especially from a safety perspective and design perspective, said Joe S., VP of CCELL.
  • Compared to other disposable vaporizers, Listo is superior because of its patented CCELL vaporizing technology, compact design, safety features, and ergonomic grip, which makes it comfortable to hold.
  • With Listo, CCELL offers consumers everything needed in a disposable vaporizer.

Rapid-Ease Offers Fast Pain Relief

Retrieved on: 
Tuesday, July 20, 2021
Health sciences, Pharmacology, Health, Dosage forms, Acute pain, Ointments, Medical terminology, Topical medication, Pain management, Pain, Cream

FORT LAUDERDALE, Fla., July 20, 2021 /PRNewswire/ --Rapid-Ease is a brand that has made its name in the pain relief industry.

Key Points: 
  • FORT LAUDERDALE, Fla., July 20, 2021 /PRNewswire/ --Rapid-Ease is a brand that has made its name in the pain relief industry.
  • The brand's Rapid-Ease Pain Relief Cream brings a particularly potent list of herbal ingredients delivered in therapeutic levels designed to genuinely "help you heal naturally."
  • Davies-Haycock's brands are founded on a commitment to creating fast-acting, effective topical pain relief products.
  • As a topical product, Rapid-Ease Pain Relief Cream has been carefully formulated by renowned natural cosmetic chemist Susan Hall to maximize absorption through a unique penetration system.

RYAH Group Partners with the University of Milan to Develop Conversion Measurement Standards for Dry Herb Inhalation Therapies

Retrieved on: 
Monday, July 19, 2021
Health sciences, Articles, Health care, Dosage forms, Respiratory therapy, Asthma, Inhaler, Vectura Group, Pharmaceutical industry, Internet of things, Dosing

The RYAH Smart Dry Herb Inhaler is an IoT-powered dry herb inhaler with an integrated volumetric airflow sensor that gives consumers the ability to track and control exactly how much they inhale.

Key Points: 
  • The RYAH Smart Dry Herb Inhaler is an IoT-powered dry herb inhaler with an integrated volumetric airflow sensor that gives consumers the ability to track and control exactly how much they inhale.
  • In furtherance of the collaboration, a team of scientists at the University of Milan is expected to undertake a study that has the potential to transform the dry herb prescription domain.
  • This is a precedent-setting experiment that is expected to generate the data needed to facilitate an accurate milligram dosing experience with dry herb.
  • Philip Morris International recently offered 1 billion to buy Vectura Group PLC, the British pharmaceutical company that develops inhaled medical products.

Genix Pharmaceuticals Corp. Receives Approval for Drug Establishment License

Retrieved on: 
Thursday, July 15, 2021
Health sciences, Pharmacology, Health care, Pharmaceutical industry, Dosage forms, Pharmacy, Capsule, Medication, Prescription drug, Cream, Pharmaceutics

Vancouver, British Columbia--(Newsfile Corp. - July 15, 2021) - Genix Pharmaceuticals Corporation (TSXV: GENX) (OTCQB: GENPF) ("GENIX" or the "Company") Genix is pleased to announce that, pursuant to a Health Canada Drug Establishment License (DEL) inspection, carried out at its warehouse premises on June 22, 2021, the Company has now received a Notice of Compliant Rated Inspection with a compliant (C) rating.

Key Points: 
  • Vancouver, British Columbia--(Newsfile Corp. - July 15, 2021) - Genix Pharmaceuticals Corporation (TSXV: GENX) (OTCQB: GENPF) ("GENIX" or the "Company") Genix is pleased to announce that, pursuant to a Health Canada Drug Establishment License (DEL) inspection, carried out at its warehouse premises on June 22, 2021, the Company has now received a Notice of Compliant Rated Inspection with a compliant (C) rating.
  • Health Canada will now formally issue the Company its Drug Establishment License (DEL) for both sterile and non-sterile finished dosage prescription drugs for all the various finished dosage forms - capsules, tablets, creams, powders and solutions.
  • President Mahmoud S. Aziz states, "It has been comprehensive and detailed process to receive the DEL approval.
  • I would like to thank our Regulatory Team and everyone involved for all of their hard work and dedication in achieving this.

Neurobiologix is Proud to Announce the Release of Clinical CBD Oil Formulas

Retrieved on: 
Thursday, July 15, 2021
Drugs, Dosage forms, Health sciences, Health care, Anticonvulsants, Cannabidiol, Cannabinoids, Resorcinols, Softgel, CBD, Dose

AUSTIN, Texas, July 15, 2021 /PRNewswire/ -- Neurobiologix, an Austin based nutritional supplement company that specializes in physician designed, GMP Certified supplements, is extremely excited to launch a new line of clinical CBD formulas.

Key Points: 
  • AUSTIN, Texas, July 15, 2021 /PRNewswire/ -- Neurobiologix, an Austin based nutritional supplement company that specializes in physician designed, GMP Certified supplements, is extremely excited to launch a new line of clinical CBD formulas.
  • The hemp-derived, cannabidiol-rich creams, soft gels and great tasting drops have been launched on www.NeurobioCBD.com after more than a year in development.
  • Neurobiologix's new range of natural clinical CBD cream, soft gels and oil drops are specially formulated by Neurobiologix to deliver a consistent daily dose of pure, premium CBD isolate.
  • At launch, the Neurobiologix CBD product line includes:
    Neurobiologix CBD Softgels in 10mg, 15mg, and 20mg dosing per softgel
    Neurobiologix CBD Drops in 10mg, 13mg, 26mg, 39mg per serving (Peach, Mint, Cinnamon and Unflavored)
    View original content to download multimedia: https://www.prnewswire.com/news-releases/neurobiologix-is-proud-to-annou...

DaVinci Advances Cannabis Vaporizer Product Line with Next Generation Device

Retrieved on: 
Tuesday, July 13, 2021
Alternative medicine, Health, Retail, Tobacco, Specialty, Dosage forms, Technology, DaVinci, HTML5, JavaScript, Mobile technology, IQC, DAVINCI+, Vaporizer, Health sciences, Pharmacology

DaVinci , the leader in clean cannabis tech and manufacturer of premium vaporizer devices, has announced the launch of its new IQC vaporizer .

Key Points: 
  • DaVinci , the leader in clean cannabis tech and manufacturer of premium vaporizer devices, has announced the launch of its new IQC vaporizer .
  • The DaVinci IQC is the embodiment of our continued commitment to customer satisfaction, said Cortney Smith, CEO and founder of DaVinci.
  • Like all DaVinci devices, the IQC has no metals or plastics in the sealed zirconia glass airpath.
  • Since DaVincis founding, the team has established a legacy in creating trusted products such as the DaVinci Classic, the DAVINCI IQ and the IQ2.

Global Respiratory Care Devices Markets, 2015-2020 & 2021-2026: Chronic Obstructive Pulmonary Disease, Asthma, Sleep Apnea, Infectious Disease - ResearchAndMarkets.com

Retrieved on: 
Tuesday, July 13, 2021
Medical devices, Health, Medicine, Health care, Clinical medicine, Respiratory therapy, Medical equipment, Dosage forms, Intensive care medicine, Mechanical ventilation, Nebulizer, Positive airway pressure, Humidifier, Respiratory therapist

The global respiratory care devices market exhibited strong growth during 2015-2020.

Key Points: 
  • The global respiratory care devices market exhibited strong growth during 2015-2020.
  • Looking forward, the global respiratory care devices market to grow at a CAGR of around 11% during the forecast period (2021-2026).
  • Nebulizers, inhalers, positive airway pressure (PAP) devices, spirometers, humidifiers, etc., are some of the most commonly used respiratory care devices.
  • What is the structure of the global respiratory care devices industry and who are the key players?

SPI Pharma launches UltraBurst™, the first in class preformulated platform for flash orally dispersible tablets

Retrieved on: 
Monday, July 12, 2021
Dosage forms, Health sciences, Pharmacology, Health care, Food and Drug Administration, Orally disintegrating tablet, Tablet, ODT

WILMINGTON, Del., July 12, 2021 /PRNewswire/ --SPI Pharma introduces UltraBurst, providing a step-change in the most critical orally disintegrating tablet (ODT) characteristics dissolution time.

Key Points: 
  • WILMINGTON, Del., July 12, 2021 /PRNewswire/ --SPI Pharma introduces UltraBurst, providing a step-change in the most critical orally disintegrating tablet (ODT) characteristics dissolution time.
  • It is an innovative excipient platform for flash ODTs, enabling disintegration in under ten seconds.
  • SPI Pharma launches first in class flash ODT drug delivery system, disintegrating in less than 10 seconds.
  • SPI Pharma brings nearly two decades of hands-on experience to the challenge of delivering a premium platform to improve ODT performance and patient experience.